---
schema_version: "secwatch.filing_event.v1"
accession: "0001682852-22-000029"
form_type: "8-K/A"
ticker: "MRNA"
cik: "0001682852"
company_name: "Moderna, Inc."
filed_at: "2022-05-13T23:59:59+00:00"
generated_at: "2026-06-25T16:50:28.227957+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Moderna enters separation agreement with former CFO; includes clawback tied to Dentsply probe

## Summary
- CFO Jorge Gomez departed May 10; separation agreement signed May 13, 2022.
- Severance of $700K salary (12 months) plus 12 months COBRA premium assistance.
- Company can claw back benefits if Gomez is found to have engaged in wrongdoing or faces fines in Dentsply/SEC investigation.
- Gomez released all claims against Moderna; non-compete waived; other restrictive covenants remain.

## SEC filing metadata
- accession: 0001682852-22-000029
- form_type: 8-K/A
- ticker: MRNA
- cik: 0001682852
- company_name: Moderna, Inc.
- filed_at: 2022-05-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1682852/000168285222000029/0001682852-22-000029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1682852/000168285222000029/mrna-20220510.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001682852-22-000029
- JSON: https://secwatch.observer/filing/0001682852-22-000029.json
- Plain text: https://secwatch.observer/filing/0001682852-22-000029.txt

## Key facts
- Executive change
  Jorge Gomez departed as Chief Financial Officer at Moderna, Inc..
  - Action: departed
  - Role: Chief Financial Officer
  source text: Jorge Gomez departed from the role of Chief Financial Officer of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682852/000168285222000029/0001682852-22-000029-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.